Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India.

Sharma HJ, Padbidri VS, Kapre SV, Jadhav SS, Dhere RM, Parekh SS, Dudhane AD, Shewale SD, Namjoshi GS.

J Infect Dev Ctries. 2011 Dec 13;5(12):874-81.

2.

Sero-surveillance to assess rubella susceptibility and assessment of immunogenicity and reactogenicity of rubella vaccine in Indian girls aged 18-24 years.

Phalgune DS, Yervadekar RC, Sharma HJ, Dhere RM, Parekh SS, Chandak AO, Safai AA, Shewale SD.

Hum Vaccin Immunother. 2014;10(10):2813-8. doi: 10.4161/21645515.2014.970947. Epub 2014 Nov 21.

3.

Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data.

Artimos de Oliveira S, Bastos Camacho LA, Uzeda Barreto MC, Coca Velarde LG, Siqueira MM.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S664-8. doi: 10.1093/infdis/jir356.

PMID:
21954264
4.

Seroprevalence of rubella among Jordanian women of childbearing age.

Jarour N, Hayajneh WA, Balbeesi A, Otoom H, Al-Shurman A, Kharabsheh S.

Vaccine. 2007 May 4;25(18):3615-8. Epub 2007 Jan 23.

PMID:
17280747
5.

Seroepidemiology of rubella in northern Greece.

Gioula G, Diza-Mataftsi E, Alexiou-Daniel S, Kyriazopoulou-Dalaina V.

Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):631-3. Epub 2004 Jul 8.

PMID:
15243817
6.

Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008.

Castillo-Solórzano C, Reef SE, Morice A, Vascones N, Chevez AE, Castalia-Soares R, Torres C, Vizzotti C, Ruiz Matus C.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S713-7. doi: 10.1093/infdis/jir489.

PMID:
21954271
7.
8.

Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.

Soleimanjahi H, Bamdad T, Fotouhi F, Roustai MH, Faghihzadeh S.

J Clin Virol. 2005 Oct;34(2):153-4.

PMID:
16076562
9.

Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.

Riddell M, Senn N, Clements CJ, Hobday L, Cowie B, Kurubi J, Kevin A, Siba P, Reeder JC, Morgan C.

Vaccine. 2012 Dec 14;30(52):7506-12. doi: 10.1016/j.vaccine.2012.10.051. Epub 2012 Oct 25.

PMID:
23103194
10.

[Rubella seroprevalence in Tunisian childbearing women two years after vaccination program introduction].

Chaabouni M, Messadi F, Fki L, M Z, Hammami A, Karray H.

Pathol Biol (Paris). 2012 Jun;60(3):170-3. doi: 10.1016/j.patbio.2011.01.002. Epub 2012 May 9. French.

PMID:
22578467
11.

Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.

Minussi L, Mohrdieck R, Bercini M, Ranieri T, Sanseverino MT, Momino W, Callegari-Jacques SM, Schuler-Faccini L.

Reprod Toxicol. 2008 Jan;25(1):120-3. Epub 2007 Sep 16.

PMID:
17977696
12.

Burden of Congenital Rubella Syndrome (CRS) in India: a systematic review.

Dewan P, Gupta P.

Indian Pediatr. 2012 May;49(5):377-99. Review.

13.

Rubella seroprevalence among Turkish adolescent girls living in Edirne, Turkey.

Oner N, Vatansever U, Karasalihoglu S, Tatman Otkun M, Ekuklu G, Küçükugurluoglu Y.

Turk J Pediatr. 2006 Oct-Dec;48(4):288-93.

PMID:
17290561
14.

Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.

Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW.

Vaccine. 2006 Jul 17;24(29-30):5772-7. Epub 2006 May 4.

PMID:
16759764
15.

Seroprevalence of rubella in school girls and pregnant women.

Karakoc GB, Altintas DU, Kilinc B, Karabay A, Mungan NO, Yilmaz M, Evliyaoglu N.

Eur J Epidemiol. 2003;18(1):81-4.

PMID:
12705627
16.
17.

Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India.

Vijayalakshmi P, Anuradha R, Prakash K, Narendran K, Ravindran M, Prajna L, Brown D, Robertson SE.

Bull World Health Organ. 2004 Apr;82(4):259-64.

18.

Pregnancy outcomes following rubella vaccination: a prospective study in the state of Rio de Janeiro, Brazil, 2001-2002.

da Silva e Sá GR, Camacho LA, Stavola MS, Lemos XR, Basílio de Oliveira CA, Siqueira MM.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S722-8. doi: 10.1093/infdis/jir408.

PMID:
21954273
19.

Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey.

Aksit S, Egemen A, Ozacar T, Kurugol Z, Keskinoglu P, Tasbakan M, Caglayan S.

Pediatr Infect Dis J. 1999 Jul;18(7):577-80.

PMID:
10440431
20.

Rubella in the Russian Federation: epidemiological features and control measures to prevent the congenital rubella syndrome.

Semerikov VV, Lavrentyeva IN, Popov VF, Fletcher MA, Kolotov ME.

Epidemiol Infect. 2000 Oct;125(2):359-66.

Supplemental Content

Support Center